Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-17

Clinical Trial Update: Dexmedetomidine Addition to Fascia Iliaca Compartment Block [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Dexmedetomidine as an adjunct to fascia iliaca block for pediatric femur fracture analgesia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Mansoura University | Conditions: Children With Fracture Femur | Phase 1 | Status: COMPLETED